Compare TFX & FHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TFX | FHI |
|---|---|---|
| Founded | 1943 | 1955 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 4.3B |
| IPO Year | 1994 | 1998 |
| Metric | TFX | FHI |
|---|---|---|
| Price | $120.00 | $57.09 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 5 |
| Target Price | ★ $138.75 | $54.20 |
| AVG Volume (30 Days) | 652.4K | ★ 682.6K |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | 1.14% | ★ 2.37% |
| EPS Growth | N/A | ★ 58.82 |
| EPS | N/A | ★ 5.13 |
| Revenue | ★ $1,992,713,000.00 | $1,102,924,000.00 |
| Revenue This Year | $15.97 | $9.90 |
| Revenue Next Year | $5.15 | $4.35 |
| P/E Ratio | ★ N/A | $11.20 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $100.18 | $35.88 |
| 52 Week High | $138.93 | $58.60 |
| Indicator | TFX | FHI |
|---|---|---|
| Relative Strength Index (RSI) | 63.79 | 53.70 |
| Support Level | $117.09 | $51.25 |
| Resistance Level | $123.74 | $57.28 |
| Average True Range (ATR) | 3.28 | 1.43 |
| MACD | 0.93 | -0.03 |
| Stochastic Oscillator | 99.44 | 57.10 |
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.
Federated Hermes provides asset management services for institutional and individual investors. The firm had $902.6 billion in managed assets at the end of 2025, composed of equity (11%), multi-asset (less than 1%), fixed-income (11%), alternative (2%), and money market (76%) funds. The firm's cash management operations are expected to generate around 55% of Federated's revenue this year, compared with 27%, 10%, and 8%, respectively, for the equity, fixed-income, and alternatives/multi-asset/other operations. The company's products are distributed via trust banks, wealth managers, and retail broker/dealers (68% of AUM), institutional investors (25%), and international clients (7%).